Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

6.5%

2 terminated out of 31 trials

Success Rate

84.6%

-1.9% vs benchmark

Late-Stage Pipeline

16%

5 trials in Phase 3/4

Results Transparency

18%

2 of 11 completed with results

Key Signals

2 with results85% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (4)
P 1 (2)
P 2 (7)
P 3 (5)

Trial Status

Completed11
Unknown11
Recruiting6
Terminated2
Active Not Recruiting1

Trial Success Rate

84.6%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT03475186Phase 2Completed

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

NCT06181656Recruiting

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

NCT04821843Phase 3Recruiting

Neoadjuvant Treatment Modalities in Esophageal Cancer

NCT04821778Phase 3Recruiting

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

NCT03013010Phase 3Completed

PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy

NCT03840239Phase 2Active Not Recruiting

TNT to Increase the Clinical Complete Response Rate for Distal LARC

NCT03283527Unknown

Organoid Based Response Prediction in Esophageal Cancer

NCT03066271Not ApplicableUnknown

Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer

NCT03623737Phase 2Unknown

Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC

NCT05394415Phase 1Unknown

Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC

NCT03170115Phase 2Terminated

Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer

NCT02813967Phase 3Completed

S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer

NCT02979691Phase 2Completed

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

NCT03461341Completed

European iNvestigation of SUrveillance After Resection for Esophageal Cancer

NCT03021668Not ApplicableCompleted

Comparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site Infections

NCT02139488Completed

Organ Motion and Early Tumor Response Measurement

NCT03923309Completed

Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer

NCT03792854Recruiting

Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)

NCT03298204Completed

Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01

NCT03731130Recruiting

Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer

Scroll to load more

Research Network

Activity Timeline